Advancing Innovative Plasmid DNA Manufacturing Solutions For Cell And Gene Therapy

Aldevron is a global leader in plasmid DNA manufacturing, providing innovative solutions for cell and gene therapies. With over 25 years of experience, Aldevron offers comprehensive services from research through clinical development to commercial supply, enabling transformative therapies that improve patients’ lives. Its proprietary Nanoplasmid™ vector system features a small backbone (<500 bp) and non-antibiotic selection marker, ensuring high transgene expression, reduced toxicity, and scalable manufacturing yields.

Operating from purpose-built facilities, including one of the world’s largest cGMP plasmid DNA manufacturing sites, Aldevron ensures precision, quality, and regulatory compliance. Supporting over 15 commercial therapy programs globally, it empowers scientists with cutting-edge tools, personalized services, and regulatory support, advancing genomic medicine and addressing unmet medical needs.